SG/CALL/STRYKER CORP./400/0.1/20.12.24 Stock

Warrant

DE000SW7ETQ4

Market Closed - Börse Stuttgart 04:14:04 2024-05-17 EDT
0.49 EUR 0.00% Intraday chart for SG/CALL/STRYKER CORP./400/0.1/20.12.24
Current month-40.24%
1 month-49.48%
Date Price Change
24-05-17 0.49 0.00%
24-05-16 0.49 +40.00%
24-05-15 0.35 -7.89%
24-05-14 0.38 -25.49%
24-05-13 0.51 -7.27%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 04:14 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ETQ
ISINDE000SW7ETQ4
Date issued 2024-03-07
Strike 400 $
Maturity 2024-12-20 (215 Days)
Parity 10 : 1
Emission price 1.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.78
Lowest since issue 0.35
Spread 0.02
Spread %3.51%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW